Findings confirm the efficacy of the SELUTION sirolimus-coated technology
A first patient has been treated in the EVAS2 IDE Confirmatory Clinical Study of the Nellix® EndoVascular Aneurysm Sealing system.
Endovascular stent graft study promises clinical results later this year
FDA allows study expansion and grants system “Breakthrough Device” status
Updated TCAR data from Silk Road Medical’s ROADSTER 1 and 2 studies presented at VEITH Symposium
Data Presented at 10th Society of Vascular and Interventional Annual Meeting
Seems the promise is realised as new clinical data suggests 3D stent technology outperforms straight comparator
High risk CLI patients avoid amputation at 12 months
Unique catheter-based device for the treatment of advanced PAD/Critical Limb Ischemia
Positive two year data reported from Nellix® EVAS FORWARD IDE Trial
First prospective clinical trial to evaluate endovascular aneurysm repair (EVAR) in women
Study paves the way for further sirolimus vs paclitaxel balloon trials below the knee
Results of ASTER study presented at International Stroke Conference
Additional funding from existing investors supports regulatory progress in USA and Japan
GORE® VIABAHN® VBX becomes the only device of its type to gain indication
PulseRider will complement Codman Neuro’s neurovascular portfolio of products for hemorrhagic and ischemic stroke.